FGF21 and metabolic dysfunction-associated steatotic liver disease: Although the benefit of FGF21 on NAFLD have been testified in many studier, it is still controversial whether the liver is a direct target organ for FGF21 action or indirect target via the adipose tissue or central nervous system (11).